Company News

Evonik and Demetrix Sign Cannabinoids Accord

Will bring a CBG product to market this year.

Author Image

By: Christine Esposito

Editor-in-Chief

Evonik and biotech company Demetrix, Berkeley, CA, have inked a supply agreement for cannabinoids to be used in beauty and personal care products. The first product, CBG (cannabigerol), will be entering the market in 2022. “Evonik is a global leader in supplying innovative solutions to the beauty and personal care markets in more than 100 countries,” says Cynthia Bryant, Demetrix CBO. “This partnership speaks to the growing demand for high purity cannabinoids because of the ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters